Ehab L Atallah
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia (NCT05038644) | Ehab L Atallah | 2022-02-02 |
Track Ehab L Atallah automatically
Every clearance here is in the API, with alerts when new ones post.